BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
84 hedge funds and large institutions have $216M invested in Bellicum Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 19 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
-12
Holders Change %
-12.5%
% of All Funds
2.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
39
Reduced
19
Closed
33
Calls
$354K
Puts
$2.49M
Net Calls
-$2.13M
Net Calls Change
-$789K
Top Buyers
| 1 |
1
BlackRock
New York
|
$25.7M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$28.8M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$14.1M |
| 4 |
NI
4
Numeric Investors
Boston,
Massachusetts
|
$1.14M |
| 5 |
5
Goldman Sachs
New York
|
$1.61M |
